Vitrolife AB (publ) (OTCMKTS:VTRLY – Get Free Report) saw a significant increase in short interest in the month of June. As of June 30th, there was short interest totaling 170 shares, an increase of ∞ from the June 15th total of 0 shares. Based on an average daily volume of 60 shares, the days-to-cover ratio is presently 2.8 days.
Vitrolife AB (publ) Stock Performance
OTCMKTS:VTRLY opened at $9.50 on Thursday. Vitrolife AB has a 52 week low of $9.50 and a 52 week high of $18.55. The stock’s fifty day moving average is $10.72 and its two-hundred day moving average is $11.63.
About Vitrolife AB (publ)
Vitrolife AB (publ) is a Sweden‐based life science company specializing in products and systems for in vitro fertilization (IVF) and assisted reproductive technologies. Founded in 1994 and headquartered in Gothenburg, the company develops, manufactures and markets a comprehensive portfolio of consumables, culture media and instruments that support the entire IVF process, from gamete handling to embryo culture and cryopreservation.
The company’s product range includes embryo culture media, blastocyst media, vitrification solutions and pipetting tools designed to optimize laboratory workflows and improve outcomes for fertility clinics and patients.
Recommended Stories
- Five stocks we like better than Vitrolife AB (publ)
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Receive News & Ratings for Vitrolife AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitrolife AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
